Shortage outlook · all drugs · read October 2026
How long has Liraglutide been on the FDA shortage list?
Liraglutide has been on the FDA shortage list for 3 years and 3 months. 102 of the 397 listings measured since 2014 lasted at least that long. Of the 102 past listings that reached the same age, 94% were still listed 6 months later (85 listings measured), 78% were still listed 12 months later (70 listings measured) and 62% were still listed 24 months later (51 listings measured). These are counts of listings, not a forecast.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.
Liraglutide has been on the FDA shortage list for 3 years and 3 months (August 2023 to October 2026).
- 102 of the 397 listings measured since 2014 lasted at least that long.
- Of the 102 past listings that reached the same age, 94% were still listed 6 months later (85 listings measured), 78% were still listed 12 months later (70 listings measured) and 62% were still listed 24 months later (51 listings measured).
- None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.
The listing history, to scale
- Liraglutide InjectionListed since August 2023 · 3 years and 3 months
What past listings of this age did
Of past listings that had already run 3 years and 3 months, how many were still listed later?
What the FDA list says about it today
Reasons companies gave: delay in shipping of the drug (2) and discontinuation of the manufacture of the drug (1); 6 of 9 gave none. FDA category: Endocrinology/Metabolism.
Company by company
Of 9 presentations, the companies reported 6 available, 3 with limited availability and 0 unavailable. This is each company's own report to the FDA, with the date of its last update.
- Novo Nordisk, Inc.5 presentations · last updated 22 September 2026
- Hikma Pharmaceuticals USA, Inc.2 presentations · last updated 14 October 2026
- Meitheal Pharmaceuticals, Inc.2 presentations · last updated 27 August 2026
FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.
Where can you go from this result?
This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.
- Lisdexamfetamine (Vyvanse generics)39 months
- Methylphenidate (Ritalin and Concerta generics)39 months
- Sterile Water37 months
- Dextrose Monohydrate 10%37 months
To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.